当前位置: X-MOL 学术Cell Host Microbe › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Approaches and Challenges in SARS-CoV-2 Vaccine Development.
Cell Host & Microbe ( IF 20.6 ) Pub Date : 2020-08-10 , DOI: 10.1016/j.chom.2020.08.002
Gabriel Dagotto 1 , Jingyou Yu 1 , Dan H Barouch 2
Affiliation  

The explosive spread of SARS-CoV-2 suggests that a vaccine will be required to end this global pandemic. Progress in SARS-CoV-2 vaccine development to date has been faster than for any other pathogen in history. Multiple SARS-CoV-2 vaccine candidates have been evaluated in preclinical models and are currently in clinical trials. In this Perspective, we discuss three topics that are critical for SARS-CoV-2 vaccine development: antigen selection and engineering, preclinical challenge studies in non-human primate models, and immune correlates of protection.



中文翻译:


SARS-CoV-2 疫苗开发的方法和挑战。



SARS-CoV-2 的爆炸性传播表明需要疫苗来结束这场全球大流行。迄今为止,SARS-CoV-2 疫苗的开发进展比历史上任何其他病原体都要快。多种 SARS-CoV-2 候选疫苗已在临床前模型中进行了评估,目前正在进行临床试验。在本视角中,我们讨论了对于 SARS-CoV-2 疫苗开发至关重要的三个主题:抗原选择和工程、非人类灵长类动物模型的临床前挑战研究以及保护的免疫相关性。

更新日期:2020-09-10
down
wechat
bug